High Point Bank & Trust’s Pfizer PFE Stock Holding History

High Point Bank & Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$927K	Sell	30,081 -5,426	-15%	-$166K	0.29%	63
2016 Q3	$1.14M	Buy	35,507 +165	+0.5%	+$5.52K	0.3%	53
2016 Q2	$1.18M	Hold	35,342	–	–	0.32%	52
2016 Q1	$994K	Sell	35,342 -1,054	-3%	-$30.1K	0.26%	61
2015 Q4	$1.11M	Hold	36,396	–	–	0.29%	54
2015 Q3	$1.08M	Sell	36,396 -11,735	-24%	-$376K	0.31%	56
2015 Q2	$1.53M	Sell	48,131 -1,230	-2%	-$40.1K	0.45%	48
2015 Q1	$1.63M	Hold	49,361	–	–	0.47%	46
2014 Q4	$1.46M	Sell	49,361 -787	-2%	-$22.6K	0.49%	53
2014 Q3	$1.41M	Sell	50,148 -1,995	-4%	-$56K	0.47%	55
2014 Q2	$1.47M	Buy	52,143 +869	+2%	+$24.8K	0.48%	52
2014 Q1	$1.56M	Sell	51,274 -53	-0.1%	-$1.58K	0.51%	46
2013 Q4	$1.49M	Hold	51,327	–	–	0.49%	48
2013 Q3	$1.4M	Hold	51,327	–	–	0.49%	51
2013 Q2	$1.36M	Buy	+51,327	New	+$1.42M	0.46%	50

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

High Point Bank & Trust's PFE Position: Q4 2016 in Review

High Point Bank & Trust reduced its Pfizer (PFE) stake by 15% in Q4 2016, selling an estimated $166K and leaving 30,081 shares worth $927K. The position accounts for 0.29% of the portfolio, ranked #63.

High Point Bank & Trust first reported a position in PFE in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.63M in Q1 2015. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

High Point Bank & Trust held 30,081 shares of Pfizer worth $927K as of Q4 2016.
High Point Bank & Trust sold 5,426 Pfizer shares in Q4 2016, an estimated $166K.
Pfizer made up 0.29% of High Point Bank & Trust's portfolio in Q4 2016, its #63 holding.
High Point Bank & Trust first reported a position in Pfizer in Q2 2013 and has held it in 15 quarters since.
High Point Bank & Trust's Pfizer position peaked at $1.63M in Q1 2015.
2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on High Point Bank & Trust's 13F filing for Q4 2016, filed 28 Feb 2017.